Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7401
CALL
iShares MSCI Sweden ETF
EWD
$761M
| $395K | ﹤0.01% |
+12,000
| New | +$378K |
|
7402
Globant
GLOB
$1.75B
| $395K | ﹤0.01% |
+3,726
| New | +$371K |
|
7403
KALA BIO
KALA
$13.3M
| $395K | ﹤0.01% |
43
-10
| -19% | -$96.6K |
|
7404
Ternium
TX
$10.8B
| $395K | ﹤0.01% |
+17,934
| New | +$365K |
|
7405
PUT
Verra Mobility
VRRM
$667M
| $395K | ﹤0.01% |
+28,200
| New | +$405K |
|
7406
PUT
Vanguard Total International Stock ETF
VXUS
$163B
| $395K | ﹤0.01% |
7,100
-4,800
| -40% | -$258K |
|
7407
PUT
iShare MSCI Eurozone ETF
EZU
$9.87B
| $394K | ﹤0.01% |
9,400
+600
| +7% | +$24.3K |
|
7408
CALL
Immersion
IMMR
$254M
| $394K | ﹤0.01% |
53,000
+9,500
| +22% | +$71.1K |
|
7409
Sprott Physical Gold
PHYS
$16B
| $394K | ﹤0.01% |
32,337
-127,226
| -80% | -$1.51M |
|
|
ERF
7410
PUT
DELISTED
Enerplus Corporation
ERF
| $394K | ﹤0.01% |
55,200
-3,600
| -6% | -$23.5K |
|
7411
CALL
Akebia Therapeutics
AKBA
$243M
| $393K | ﹤0.01% |
62,200
-17,800
| -22% | -$84.6K |
|
7412
PUT
AptarGroup
ATR
$8.46B
| $393K | ﹤0.01% |
3,400
+1,000
| +42% | +$114K |
|
7413
CALL
City Holding Co
CHCO
$2.01B
| $393K | ﹤0.01% |
4,800
-2,600
| -35% | -$206K |
|
7414
CALL
St. Joe Company
JOE
$3.83B
| $393K | ﹤0.01% |
19,800
+6,900
| +53% | +$128K |
|
7415
MGE Energy Inc
MGEE
$2.95B
| $393K | ﹤0.01% |
4,988
-10,651
| -68% | -$821K |
|
|
MODN
7416
PUT
DELISTED
MODEL N, INC.
MODN
| $393K | ﹤0.01% |
+11,200
| New | +$341K |
|
7417
CALL
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$698M
| $392K | ﹤0.01% |
8,500
-900
| -10% | -$40.2K |
|
7418
PUT
ProShares UltraPro Short 20+ Year Treasury
TTT
$17.4M
| $392K | ﹤0.01% |
5,950
-175
| -3% | -$10.9K |
|
|
IMGN
7419
PUT
DELISTED
Immunogen Inc
IMGN
| $392K | ﹤0.01% |
76,800
+16,400
| +27% | +$55.7K |
|
|
CVSA
7420
Covista Inc
CVSA
$4.58B
| $391K | ﹤0.01% |
11,170
-21,266
| -66% | -$732K |
|
|
DCH
7421
Dauch Corp
DCH
$1.5B
| $391K | ﹤0.01% |
36,347
-24,127
| -40% | -$230K |
|
7422
PUT
Galectin Therapeutics
GALT
$405M
| $391K | ﹤0.01% |
136,700
+3,700
| +3% | +$12.9K |
|
7423
PUT
Smith Micro Software
SMSI
$16.3M
| $391K | ﹤0.01% |
2,455
-2,018
| -45% | -$399K |
|
|
AIMC
7424
PUT
DELISTED
Altra Industrial Motion Corp
AIMC
| $391K | ﹤0.01% |
10,800
-11,500
| -52% | -$365K |
|
|
PGNX
7425
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $391K | ﹤0.01% |
76,900
+51,500
| +203% | +$272K |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.